The relevance of PET/CT for the surgical management of neuroendocrine neoplasms

被引：0
作者：
Hommann, M. [1 ]
Kaemmerer, D. [1 ]
Hoersch, D. [2 ]
Kulkarni, H. R. [3 ]
Robiller, F. [3 ]
Baum, R. P. [3 ]
机构：
[1] Zent Klin Bad Berka, ENETS Ctr Excellence, Klin Allgemeine Chirurg Viszeralchirurg, D-99438 Bad Berka, Germany
[2] Zent Klin Bad Berka, ENETS Ctr Excellence, Klin Innere Med Gastroenterol Endokrinol, D-99438 Bad Berka, Germany
[3] Zent Klin Bad Berka, ENETS Ctr Excellence, Klin Mol Radiotherapie, Zentrum Mol Bildgebung, D-99438 Bad Berka, Germany
来源：
CHIRURG | 2014年 / 85卷 / 06期
关键词：
Neuroendocrine neoplasm; Somatostatin receptor; (68)Gallium; Positron emission tomography computed tomography; Surgery; TUMORS; THERAPY; THERANOSTICS; LOCALIZATION; TOMOGRAPHY; SURGERY; ANALOG;
D O I：
10.1007/s00104-013-2671-0
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Neuroendocrine neoplasms (NEN) are rare malignancies with a wide spectrum of metastatic potential which originate from the endocrine cells of the body and express somatostatin receptors. The (68)gallium somatostatin receptor positron emission tomography-computed tomography (PET/CT) technique is the most sensitive method of assessment of well-differentiated NENs and for the detection of cancer of unknown primary (CUP syndrome) NENs. Imaging with 18F-fluorodeoxyglucose (18F-FDG PET/CT) is indicated in poorly differentiated neuroendocrine carcinomas. The receptor-dependent imaging of NENs has a decisive impact on further management.
引用
收藏
页码：500 / 504
页数：5
相关论文
共 29 条
[1]  
Adams S, 1998, EUR J NUCL MED, V25, P79
[2]  
Al-Nahhas A, 2007, ANTICANCER RES, V27, P4087
[3]  
Anlauf M, 2011, CHIRURG, V82, P567, DOI 10.1007/s00104-011-2067-y
[4]  
Baum R. P., 2008, V170, P225
[5]   Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms [J].
Baum, Richard P. ;
Kulkarni, Harshad R. ;
Carreras, Cecilia .
SEMINARS IN NUCLEAR MEDICINE, 2012, 42 (03) :190-207
[6]   Surgical therapy of pancreatic endocrine tumors [J].
Bausch, D. ;
Keck, T. .
ONKOLOGE, 2013, 19 (03) :224-229
[7]  
Becherer A, 2004, J NUCL MED, V45, P1161
[8]   Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice.: Primary and secondary evaluation for localization of phaeochromocytomas [J].
Berglund, AS ;
Hulthén, UL ;
Manhem, P ;
Thorsson, O ;
Wollmer, P ;
Törnquist, C .
JOURNAL OF INTERNAL MEDICINE, 2001, 249 (03) :247-251
[9]   Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA(0),D-Phe(1),Tyr(3)]octreotide, a promising somatostatin analogue for radionuclide therapy [J].
deJong, M ;
Bakker, WH ;
Krenning, EP ;
Breeman, WAP ;
vanderPluijm, ME ;
Bernard, BF ;
Visser, TJ ;
Jermann, E ;
Behe, M ;
Powell, P ;
Macke, HR .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (04) :368-371
[10]  
Dralle H, 2013, CHIRURG, V84, P433, DOI 10.1007/s00104-013-2504-1
123